Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
Hong Kong
· Delayed Price · Currency is HKD 22.66
-1.22 (-5.11%)
At close: Dec 5, 2025
HKG:2252 Revenue
Shanghai MicroPort MedBot (Group) had revenue of 175.69M CNY in the half year ending June 30, 2025, with 269.07% growth. This brings the company's revenue in the last twelve months to 333.70M, up 113.60% year-over-year. In the year 2024, Shanghai MicroPort MedBot (Group) had annual revenue of 257.25M with 145.95% growth.
Revenue (ttm)
333.70M CNY
Revenue Growth
+113.60%
P/S Ratio
63.91
Revenue / Employee
753.28K CNY
Employees
443
Market Cap
23.37B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 38.69B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |